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Multiple organ dysfunctionAbstract Background: Little is known on the impact of risk factors that may complicate the
course of critical illness. Scoring systems in ICUs allow assessment of the severity of diseases and
predicting mortality.
Objectives: Apply commonly used scores for assessment of illness severity and identify the combi-
nation of factors predicting patient’s outcome.
Methods: We included 231 patients admitted to PICU of Cairo University, Pediatric Hospital.
PRISM III, PIM2, PEMOD, PELOD, TISS and SOFA scores were applied on the day of admis-
sion. Follow up was done using SOFA score and TISS.
Results: There were positive correlations between PRISM III, PIM2, PELOD, PEMOD, SOFA
and TISS on the day of admission, and the mortality rate (p< 0.0001). TISS and SOFA score
had the highest discrimination ability (AUC: 0.81, 0.765, respectively). Signiﬁcant positive correla-
tions were found between SOFA score and TISS scores on days 1, 3 and 7 and PICU mortality rate
(p< 0.0001). TISS had more ability of discrimination than SOFA score on day 1 (AUC: 0.843,
0.787, respectively).
Conclusion: Scoring systems applied in PICU had good discrimination ability. TISS was a good
tool for follow up. LOS, mechanical ventilation and inotropes were risk factors of mortality.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).Introduction
Mortality rate in the intensive care unit (ICU) depends on the
severity of illness and the patient population analyzed, and
6.4–10.3% of critically ill patients were reported to die.1
Although the total number of hospital beds in the United
States decreased by 26.4% from the year 1985 to 2000; the
ICU beds increased by 26.2% during the same period.2
As a fact, we know little on the exact causes of death and
the impact of risk factors that may complicate the course of
critical illness irrespective of the underlying disease.3
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would not only help improve prognostic evaluation of patients,
but also indicate what therapy and research should focus on to
improve the short and long term outcomes of those patients.4
Scoring systems for use in ICUpatients have been introduced
over the last 30 years. They allow assessment of the severity of
disease and provide an estimate of in-hospital mortality by gath-
ering routinely measured data speciﬁc to a patient.5
The aim of this study was to apply commonly used scores, in
adults and children, for assessment of illness severity and deter-
mine their relation to patient’s outcome in a developing country.Patients and methods
This is a prospective study including all patients admitted to
pediatric ICU (PICU) in Cairo University Mounira Pediatric
Hospital, over one year.
Inclusion criteria
All patients must be from the age of 1 month to the age of
14 years (As pubertal children are referred to adult ICU).
Exclusion criteria
Patients who died in the ﬁrst 24 h.
Intervention
Clinical examination and full investigations including: com-
plete blood count (CBC), arterial blood gases (ABG), full
chemistry, coagulation proﬁle, cerebrospinal ﬂuid (CSF) if
needed, cultures (blood culture, urine culture, others if
needed), Radiology (X-ray, CT scan, others if needed).
Assessment of the severity of illness and mortality risk
adjustment on admission of the patient using the parameters
of the following scores:
 Pediatric risk of mortality (PRISM) III.6
 PEdiatric Multiple Organ Dysfunction (PEMOD) scoring
system.7Table 1 Scores done for the patients on admission.
Outcome Mean SD
PRISM III Died 12.9 ±9.27
Survived 5.73 ±4.86
PIM2 Died 0.22 ±0.29
Survived 0.06 ±0.10
PEMOD Died 7.05 ±3.88
Survived 4.13 ±2.82
PELOD Died 15.17 ±14.25
Survived 4.96 ±8.31
SOFA Died 10.55 ±4.50
Survived 6.34 ±3.47
TISS Died 23.62 ±8.52
Survived 14.94 ±5.16
AUC: area under the curve, PELOD: PEdiatric Logistic Organ Dysfunct
scoring system, PIM2: revised Pediatric Index of Mortality score, PRISM
Failure Assessment, TISS: Therapeutic Intervention Scoring System. PEdiatric Logistic Organ Dysfunction (PELOD) scoring
system.7
 Pediatric Index of Mortality2 (PIM2).8
Follow up of the patient progression and level of interven-
tion using:
 Sepsis-related Organ Failure Assessment (SOFA) score.9
SOFA score was previously been used in children.10,11
 Therapeutic Intervention Scoring System (TISS).9
Although TISS score was used only in adults, we found
its parameters not assessed in other scores and we were
interested in its parameters.
Assessments of the outcome of the patients at the end of
PICU stay, regarding length of stay (LOS) and survival to
discharge.
Statistical analysis
Results were tabulated and statistical signiﬁcance was tested
using the student-t test for quantitative values and chi square
test was used for qualitative values, other tests of signiﬁcance
were used depending on results.
Results
Two hundred thirty one patients admitted to PICU in Moun-
ira Pediatric Hospital, over 1 year, were enrolled in a prospec-
tive observational study.
One hundred and eleven (48.1%) were females and 120
(51.9%) were males, deaths in both sexes were almost equal
(26.1% and 25.8% respectively).
The mortality rate was 25.9% (60 patients). Mortality rate
was higher in infants (<1 year) than in children (27%, 23%
respectively).
Respiratory problems were the highest admission diagnoses
(40.6%), followed by central nervous system (CNS) (15.1%)
and cardiovascular system (CVS) (10.8%), but the highest per-
centage of mortalities was in patients with septicemia and mul-
tiple organ dysfunction syndrome (MODS) (66.7%) and
neurological disease (51.4%).95% CI p value AUC
10.55–15.24 p< 0.0001 0.751
5.00–6.46
0.15–0.3 p< 0.0001 0.747
0.04–0.07
6.07–8.03 p< 0.0001 0.732
3.70–4.55
11.56–18.77 p< 0.0001 0.762
3.71–6.20
9.41–11.69 p< 0.0001 0.765
5.82–6.86
21.46–25.77 p< 0.0001 0.811
14.17–15.72
ion scoring system, PEMOD: PEdiatric Multiple Organ Dysfunction
III: pediatric risk of mortality score, SOFA: Sepsis-related Organ
Table 2 Following up patients on days 1, 3 and 7 using TISS and SOFA score.
Outcome Mean SD 95%CI p value
SOFA d1 Died 4.4 ±2.98 3.65–5.15 p< 0.0001
Survived 1.52 ±2.08 1.21–1.83
SOFA d3 Died 3.88 ±3.00 3.07–4.70 p< 0.0001
Survived 1.03 ±1.68 0.75–1.31
SOFA d7 Died 4 ±3.22 2.95–5.05 p< 0.0001
Survived 0.74 ±1.29 0.42–1.05
TISS d1 Died 21.93 ±8.70 19.73–24.13 p< 0.0001
Survived 11.88 ±5.22 11.10–12.67
TISS d3 Died 18.8 ±10.23 16.21–21.39 p< 0.0001
Survived 8.32 ±5.93 7.43–9.21
TISS d7 Died 12.18 ±11.23 9.34–15.02 p< 0.0001
Survived 3.90 ±5.52 3.07–4.72
Correlation is signiﬁcant at the 0.05 level.
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PRISM III, PIM2, PELOD and PEMOD on the day of admis-
sion and mortalities (p< 0.0001). TISS and SOFA score had
the highest discriminatory power (area under ROC curve
(AUC): 0.81 and 0.765, respectively) (Table 1).
Also signiﬁcant positive correlations were found between
SOFA score and TISS scores on days 1, 3 and 7 and mortali-
ties (p< 0.0001) (Table 2). TISS had more ability of discrim-
ination than SOFA score on day 1 (AUC: 0.843, 0.787,
respectively).
There were signiﬁcant correlations between LOS and TISS
on admission, day 1 and day 3 (p= 0.004, p= 0.0001 and
p< 0.0001, respectively). And the longer the LOS, the higher
the mortality risk [p= 0.004; odds ratio (OR) = 5.6 in
patients who stayed more than 15 days; 95% CI: 10.14–
22.75]. While evaluating our patients with PIM2 score, those
deﬁned as ‘‘high risk diagnosis’’ had the highest risk of mortal-
ity (54.17%, OR= 4.02).
Table 3 presents the parameters used for evaluation of dif-
ferent systems:
Patients who were intubated had higher risk of mortality
(OR = 12). ABG derangement increased risk of mortality,
especially PaO2. Death was 100% in the patients with
PaO2 < 42 mmHg.
Risk of mortality was almost doubled in infants with
systolic blood pressure (SBP) 644 mmHg or child with SBP
657 mmHg and adolescent with SBP 666 mmHg
(OR= 2.2–2.4). Also risk of mortality was doubled in infants
with heart rate 650 beat/min or a child with heart rate
640 beat/min (OR= 1.9). Risk of mortality was elevated in
patients on inotropes (OR = 8.5). Also insertion of central
venous line reﬂected the severity of the case because risk of
mortality was elevated (OR= 6.9).
Risk of mortality was high in patients with liver enzymes
>250 IU/L (OR= 3.6; ALT 95% CI: 47.86–155; AST 95%
CI: 74.96–395.28); elevated bilirubin >6 mg/dL (OR= 12.8;
95% CI: 1.93–12.1); and low albumin (OR= 4.4; 95% CI:
3.1–3.39).
There was a signiﬁcant relation between BUN and mortal-
ities (p= 0.01). The highest risk of mortality was found with
serum creatinine >5 mg/dL (OR= 17 and speciﬁcity 98.8;
95% CI: 0.67–1.29).
Risk of mortality increased with platelet count from
100,000 to 149,999 per lL (OR= 3.7; 95% CI: 276.21–371.26). And also risk of mortality doubled in patients with
PT >22 s or PTT >57 s (OR= 6.5; PT 95% CI: 20.22–
42.67; PTT 95% CI: 39.69–132.58) and was 100% in patients
who needed anti-coagulation treatment (e.g. those of post-can-
nulation thrombosis).
Risk of mortality was high in patients with potassium
P8 mEq/L (OR= 12.1; 95% CI: 4.08–4.91) or calcium from
5 to 6.9 mg/dL (OR= 5.5; 95% CI: 8.17–9.03).
Moreover, risk of mortality increased in patients with met-
abolic acidosis (OR = 12.7; speciﬁcity 97.7; pH 95% CI: 7.2–
7.33), fever and hypothermia (OR= 5.9; speciﬁcity 99.4) and
patients who needed to insert more than one peripheral line
(OR = 6; speciﬁcity 84.4).Discussion
Regarding the admission diagnoses, our results were similar to
a study in Barbados, showing that respiratory illnesses were
(33%) followed by CNS (22%) and CVS problems (14%).12
Also, Typpo et al. and Costa et al. demonstrated that the pres-
ence of MODS on the ﬁrst day of hospitalization was related
to higher mortality.13,14
In our study mean PRISM III was higher in non-survivors
than in survivors (12.9 ± 9.2 and 5.7 ± 4.8 respectively). El-
Nawawy and colleagues found similar results.15 In many stud-
ies, PRISM III showed satisfactory performance in differenti-
ating survivors from non-survivors, supporting the conclusion
that higher scores are correlated with increased risk of
death.14,16 In contrast some authors have shown that the
PRISM score overestimated mortality.17
In our study PELOD score was signiﬁcantly higher in non-
survivors than in survivors and there was a signiﬁcant correla-
tion between the score and the mortalities.
Similarly, another study found that the risk of mortality
was directly proportional to the degree of organ dysfunction
and PELOD score increased with the number of organ
dysfunction.18
Our results regarding PEMOD score were consistent with
Graciano and colleagues as they found progressive increase
in PEMOD score yielded stepwise increase in overall mortality
rate.19
In the present study we found a positive correlation
between SOFA score (and TISS scores) on the day of












Intubations 62 39 (62.9%) 12 65 86.5
PaO2
 P60 mmHg 212 46 (21.7%)
 50–59 mmHg 12 8 (66.7%) 10.1 23.3 97.1
 42–49 mmHg 5 4 (80%) 18.9 10 99.4
 <42 mmHg 2 2 (100%) 3.33 100
Cardiovascular
PRISM III (SBP)
 Infant > 65 mmHg, child > 75 mmHg, adolescent > 85 mmHg 196 48 (24.5%)
 Infant 45–65 mmHg, child 55–75 mmHg, adolescent 65–85 mmHg 10 2 (20.0%) 1.6 20 86.5
 Infant < 45 mmHg, child < 55 mmHg, adolescent < 65 mmHg
AND >205 bpm OR adolescent (>155 bpm)
25 10 (40%) 2.4 16.7 92.4
Dopamine/Dobutamine
No inotropes 185 31 (16.8%)
 65 lg/kg/min 4 2 (50.0%) 8.5 48.3 90.1
 >5–10 lg/kg/min 16 10 (62.5%) 8.5 45 91.2
 >10–15 lg/kg/min 15 9 (60.0%) 7.1 28.3 94.7
 >15 lg/kg/min 11 8 (72.7%) 8.6 13.3 98.2
Central venous line 18 12 (66.7%) 6.9 20 96.5
Liver functions
Alanine Aminotransferase
Normal 112 20 (17.9%)
Elevated 80 22 (27.5%) 2.3 66.7 53.8
 P100–250 IU/L 20 8 (40.0%) 3.1 30 87.7
 P250–800 IU/L 14 8 (57.1%) 3.6 16.7 94.7
 P800 IU/L 5 2 (40.0%) 1.9 3.3 98.2
Bilirubin (mg/dL)
 61.2 24 6 (25%)
 >1.2–2 2 2 (100%) 4 57.1 75
 >2–3.5 2 0 (0%) 2.3 42.9 75
 >3.5–6 4 1 (25%) 3.8 42.9 83.3
 >6–12 4 3 (75%) 12.8 35.7 95.8
 >12 2 2 (100%) 14.3 100
Albumin (g/dL)
 >3 191 39 (20.4%)
 2–3 35 18 (51.4%) 4.3 35 88.9
 1.2–2 5 3 (60%) 4.4 5 98.8
 61.2 0 0
Kidney function
SOFA (serum creatinine)
 <1.2 mg/dL 178 30 (16.9%)
 1.0–1.9 mg/dL 5 1 (20%) 6.4 50 86.5
 2.0–3.4 mg/dL 1 1 (100%) 7.5 48.3 88.9
 3.5–4.9 mg/dL 30 14 (46.7%) 7 46.7 88.9
 >5.0 mg/dL 17 14 (82.4%) 17 23.3 98.2
Hematological system
SOFA (Platelets)
 P150,000 per lL 204 46 (22.5%)
 100,000–149,999 per lL 8 5 (62.5%) 3.7 23.3 92.4
 50,000–99,999 per lL 11 7 (63.6%) 2.8 15 94.2
 20,000–49,999 per lL 8 2 (25%) 0.9 3.3 96.5
 <20,000 per lL 0 0 (0%)
PT or PTT
 Normal 6 0 (0%)
 1.5 Normal 13 5 (38.5%) 100 35.3
 PT> 22 s or PTT > 57 s 10 7 (70%) 6.5 58.3 82.4
Electrolyte
Potassium (mEq/L)
 3.1–6.4 197 43 (21.8%)
 6.5–6.9 22 9 (40.9%) 3.6 28.3 90.1












 7–7.49 6 4 (66.7%) 6.4 13.3 97.7
 7.5–7.9 1 0 (0%) 6 6.7 98.8
 P8 5 4 (80%) 12.1 6.7 99.4
Calcium (mg/dL)
 8–11.9 193 42 (21.8%)
 7–7.9 or P12 27 11 (40.7%) 3.2 30 88.3
 5–6.9 6 5 (83.3%) 5.5 11.7 97.7
 <5 5 2 (40%) 1.9 3.3 98.2
Application of different scoring systems 63admission and mortalities. And we found a strong correlation
between SOFA score, PELOD and PEMOD scores on admis-
sion. Muehler and colleagues reported that TISS score was
higher in patients who died. But the mean TISS score on the
day of ICU admission was much higher than in our study. This
difference was because they included more surgical patients
who needed more procedures which increase the value of this
score.20
Contrary to our results, Ho and colleagues found no signif-
icant relation between SOFA on the day of admission and
mortality (p= 0.437).21 This difference was due to high mor-
tality rate in our patients from sepsis.
We found a signiﬁcant correlation between TISS on admis-
sion, day 1, day 3 and day 7 and SOFA score on admission,
day 1, day 3 and day 7. Several studies have also reported a
good correlation between TISS score and SOFA score.20,22,23
We found a signiﬁcant positive relation between LOS and
deaths. Two studies found that the mean LOS was longer in
non-survivors when compared with survivors, but with no sta-
tistical signiﬁcance between LOS and mortalities.12,18
In our study, the use of vaso-active drugs was a risk factor
for death, corroborating the ﬁndings of other authors who
showed higher mortality rates in patients using these drugs.24
Graciano and colleagues, 2005 study was similar to our
results regarding the absence of relation between bilirubin
and mortality rate; and the presence of positive correlation
between BUN and mortality rate.19
High potassium was a risk of mortality, this may be
explained by the fact that hyper-kalemia is a potential cause
for lethal arrhythmias.25 Same was found with hypo-calcemia,
which may cause tetany, seizures and may be complicated by
life threatening laryngospasm and cardiac arrhythmias.26Conclusions and recommendations
PRISM III, PIM2, PELOD, PEMOD, SOFA and TISS
applied in our PICU were signiﬁcantly correlated to risk of
mortality. SOFA score and TISS had better discrimination
ability on admission. TISS was a good tool for following up
patients and predicting mortality. LOS, mechanical ventilation
and inotropes increased risk of mortality.
We recommend:
 The use of SOFA score and TISS in PICU for evaluating
the patients on admission and predicting risk of mortality.
 The use of TISS can be enough for follow up. We recommend gathering different important risk factors in
a new score including PaO2/FiO2, use of mechanical venti-
lation, MAP (mean air way pressure), use of inotropes, glas-
gow coma scale (GCS), papillary reﬂex, pH, serum Ca and
K level, bilirubin level, coagulation proﬁle, albumin, urine
output, dialysis, arrest and deﬁbrillation.
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